We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Hikma Pharmaceuticals Plc | LSE:HIK | London | Ordinary Share | GB00B0LCW083 | ORD SHS 10P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
-4.00 | -0.20% | 1,956.00 | 1,964.00 | 1,966.00 | 2,000.00 | 1,959.00 | 1,994.00 | 330,344 | 16:35:20 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
Pharmaceutical Preparations | 2.88B | 192M | 0.8685 | 22.64 | 4.35B |
TIDMHIK
RNS Number : 9861Q
Hikma Pharmaceuticals Plc
05 December 2016
Notification and public disclosure of transactions by persons discharging managerial responsibilities
The attached individual notification made under article 19.1 of the Market Abuse Regulation ("MAR") relates to the purchase by HMS Holdings SAL of Ordinary Shares of 10 pence each in Hikma Pharmaceuticals PLC. The Chairman and Chief Executive, and the Vice Chairman shareholders in HMS Holdings SAL. This announcement is made in accordance with article 19.3 of MAR.
Said Darwazah
1 Details of the person discharging managerial responsibilities / person closely associated --- --------------------------------------------------------------- a) Name Said Darwazah --- --------------------- ---------------------------------------- 2 Reason for the notification --- --------------------------------------------------------------- a) Position/status Chairman and Chief Executive Officer / PDMR --- --------------------- ---------------------------------------- b) Initial notification Initial notification /Amendment --- --------------------- ---------------------------------------- 3 Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor --- --------------------------------------------------------------- a) Name Hikma Pharmaceuticals PLC --- --------------------- ---------------------------------------- b) LEI 549300BNS685UXH4JI75 --- --------------------- ---------------------------------------- 4 Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted --- --------------------------------------------------------------- a) Description Description: Ordinary shares of 10 of the financial pence each instrument, ID Code: GB00B0LCW083 type of instrument and identification code --- --------------------- ---------------------------------------- b) Nature of Acquisition by HMS Holdings SAL of the transaction 350,000 Ordinary Shares of 10 pence each in Hikma Pharmaceuticals PLC. The Chairman and Chief Executive is a shareholder in HMS Holdings SAL with an equity interest of 29.16%. --- --------------------- ---------------------------------------- c) Price(s) and Price(s): GBP16.74 volume(s) Volume(s): 350,000 --- --------------------- ---------------------------------------- d) Aggregated Aggregated volume: 350,000 information Price: GBP16.74 --- --------------------- ---------------------------------------- e) Date of the 2 December 2016 transaction --- --------------------- ---------------------------------------- f) Place of the London Stock Exchange (XLON) transaction --- --------------------- ----------------------------------------
Mazen Darwazah
1 Details of the person discharging managerial responsibilities / person closely associated --- ------------------------------------------------------------ a) Name Mazen Darwazah --- --------------------- ------------------------------------- 2 Reason for the notification --- ------------------------------------------------------------ a) Position/status Executive Vice Chairman / PDMR --- --------------------- ------------------------------------- b) Initial notification Initial notification /Amendment --- --------------------- ------------------------------------- 3 Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor --- ------------------------------------------------------------ a) Name Hikma Pharmaceuticals PLC --- --------------------- ------------------------------------- b) LEI 549300BNS685UXH4JI75 --- --------------------- ------------------------------------- 4 Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted --- ------------------------------------------------------------ a) Description Description: Ordinary shares of 10 of the financial pence each instrument, ID Code: GB00B0LCW083 type of instrument and identification code --- --------------------- ------------------------------------- b) Nature of Acquisition by HMS Holdings SAL of the transaction 350,000 Ordinary Shares of 10 pence each in Hikma Pharmaceuticals PLC. The Vice Chairman is a shareholder in HMS Holdings SAL with an equity interest of 29.16%. --- --------------------- ------------------------------------- c) Price(s) and Price(s): GBP16.74 volume(s) Volume(s): 350,000 --- --------------------- ------------------------------------- d) Aggregated Aggregated volume: 350,000 information Price: GBP16.74 --- --------------------- ------------------------------------- e) Date of the 2 December 2016 transaction --- --------------------- ------------------------------------- f) Place of the London Stock Exchange (XLON) transaction --- --------------------- -------------------------------------
Peter Speirs, Company Secretary, Responsible for releasing this announcement
5 December 2016
This information is provided by RNS
The company news service from the London Stock Exchange
END
DSHBDBDDDXGBGLU
(END) Dow Jones Newswires
December 05, 2016 07:34 ET (12:34 GMT)
1 Year Hikma Pharmaceuticals Chart |
1 Month Hikma Pharmaceuticals Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions